Göran Rådegran
21 – 30 of 153
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
Extracellular Vesicle-Associated TWEAK Contributes to Vascular Inflammation and Remodeling During Acute Cellular Rejection
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension : A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
- Contribution to journal › Letter
-
Mark
Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension : A Swedish single-center study
- Contribution to journal › Article
- 2022
-
Mark
Plasma Biomarkers for Clinical Assessment of Bone Mineral Density in Heart Transplanted Patients—A Single-Center Study at Skåne University Hospital in Lund
- Contribution to journal › Article
-
Mark
Impact of bridging with left ventricular assist device on right ventricular function following heart transplantation
- Contribution to journal › Article
-
Mark
The Authors' Reply to the Letter “Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis”
- Contribution to journal › Letter
-
Mark
Data on plasma tumour and metabolism related proteins’ potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension
- Contribution to journal › Article
-
Mark
Bone mineral density in pediatric heart transplanted patients: A retrospective single-centre study at Skåne University Hospital in Lund 1988-2016
- Contribution to journal › Article
-
Mark
Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension
- Contribution to journal › Article
